Ionis Pharmaceuticals (IONS) Financials: Revenue & Earnings

IONS price $43.96 0.00 0.00%

Ticker
IONS
Price
$43.96
Change
0.00 0.00%
Market cap ?
$7.31B
P/E ?
-12.55
Forward P/E ?
109.71
Dividend yield ?
0.00%
Beta ?
0.38
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
49
Value
60
Quality
33
Growth
53

Stocklytics score rationale: value 60, quality 33, growth 53.

Financials

2016201720182019202020212022202320242025
3727760005141790005996740001122599000729264000810456000587367000787647000705138000944000000

Founded in 1989 and headquartered in Carlsbad, California, Ionis Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapies within the United States. Its commercial portfolio includes three key medications: SPINRAZA, prescribed for spinal muscular atrophy (SMA) in both children and adults; TEGSEDI, an injectable treatment targeting polyneuropathy…

Fair value

IONS fair value $13.01. Price $43.96. Price is 238% above fair value.

Above fair value, and more expensive than usual. A larger premium than on 61% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 260.21M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 166.18M. Net debt 2.24B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare IONS

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—-1.22—181.56M
2026-07-29-0.69-1.09268.00M189.10M
2026-04-29-0.56-0.85246.00M195.56M
2026-02-25-1.41-1.24203.00M156.07M
2025-10-29-0.61-1.15156.72M153.57M
2025-07-300.860.27452.05M131.75M
2025-04-30-0.75-1.11131.61M150.59M
2025-02-19-0.66-1.09226.58M131.14M
2024-11-06-0.95-1.16133.81M144.44M
2024-08-01-0.45-0.92225.25M150.07M
2024-05-07-0.98-1.05119.00M131.42M
2024-02-21-0.06-0.83324.50M174.76M
2023-11-02-1.03-1.04144.21M132.90M
2023-08-09-0.60-0.90188.41M138.83M
2023-05-03-0.87-0.91130.52M140.51M
2023-02-22-0.37-1.06151.89M160.13M
2022-11-09-0.33-0.74159.77M143.95M
2022-08-09-0.74-0.62133.79M140.54M
2022-05-04-0.46-0.71141.92M122.46M
2022-02-241.410.28440.01M275.55M
2021-11-03-0.58-0.53133.09M163.67M
2021-08-04-0.57-0.60125.75M126.00M
2021-05-05-0.64-0.53111.61M138.50M
2021-02-24-2.440.24290.28M274.45M
2020-11-04-0.22-0.09160.08M65.49M
2020-08-05-0.23-0.28145.54M177.18M
2020-05-06-0.10-0.11133.37M45.73M
2020-02-261.410.93493.68M358.69M
2019-11-060.18-0.32167.89M298.47M
2019-08-07-0.01-0.27163.81M4.42B
2019-05-090.920.43297.21M282.83M
2019-02-272.420.40192.12M4.35M
2018-11-06-0.03-0.16145.40M775.44M
2018-08-07-0.05-0.02117.75M36.54M
2018-05-04-0.01-0.01144.42M433.26M
2018-02-270.02-0.08172.30M86.15M
2017-11-07-0.02-0.05118.31M200.56M
2017-08-08-0.09-0.04112.27M96.67M
2017-05-090.03-0.10115.80M183.84M
2017-02-280.24-0.12160.35M91.63M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-16Devers Shannon L.Sell1.36K$43.5459.08K
2026-10-16Swayze EricSell53$43.542.31K
2026-10-15Devers Shannon L.Sell2.82K——
2026-10-15Devers Shannon L.Buy2.82K——
2026-10-15Swayze EricSell125——
2026-10-15Swayze EricBuy125——
2026-08-31BENNETT C FRANKBuy110$51.315.64K
2026-08-31O'NEIL PATRICK R.Buy63$51.313.23K
2026-08-31Monia Brett PBuy98$51.315.03K
2026-08-31Birchler BrianBuy58$51.312.98K
2026-07-31Hayden Michael RBuy5.00K$51.60258.00K
2026-07-30Hayden Michael RBuy15.00K$53.38800.70K
2026-07-15Reikes Peter NBuy3.40K——
2026-07-15HANTSON LUDWIGBuy3.40K——
2026-07-15HERMAN JOAN EBuy5.22K——
2026-07-15HERMAN JOAN ESell5.22K——
2026-07-15BERTHELSEN SPENCER RBuy5.22K——
2026-07-15BERTHELSEN SPENCER RSell5.22K——
2026-07-07BENNETT C FRANKSell5.54K$83.58462.69K
2026-07-07BENNETT C FRANKBuy15.00K$85.461.28M
2026-07-07BENNETT C FRANKSell15.00K$85.461.28M
2026-07-07BENNETT C FRANKSell15.00K$85.461.28M
2026-07-07Diaz Allene M.Buy10.11K$47.11476.33K
2026-07-07Diaz Allene M.Sell10.11K$85.42863.64K
2026-07-07Diaz Allene M.Sell10.11K$47.11476.33K
2026-07-07Kordasiewicz Holly B.Sell362$84.3030.52K
2026-07-01YANG MICHAEL J.Buy2.30K——
2026-07-01YANG MICHAEL J.Buy5.37K$79.19425.17K
2026-07-01LOSCALZO JOSEPHBuy2.30K——
2026-07-01LOSCALZO JOSEPHBuy5.37K$79.19425.17K
2026-07-01HERMAN JOAN EBuy2.30K——
2026-07-01HERMAN JOAN EBuy5.37K$79.19425.17K
2026-07-01KLEIN JOSEPH IIIBuy11.52K$39.94460.03K
2026-07-01KLEIN JOSEPH IIISell99$79.457.87K
2026-07-01KLEIN JOSEPH IIIBuy2.30K——
2026-07-01KLEIN JOSEPH IIISell11.42K$79.04902.55K
2026-07-01KLEIN JOSEPH IIIBuy5.37K$79.19425.17K
2026-07-01KLEIN JOSEPH IIISell11.52K$39.94460.03K
2026-07-01Hayden Michael RBuy2.30K——
2026-07-01Hayden Michael RBuy5.37K$79.19425.17K
2026-07-01Diaz Allene M.Buy2.30K——
2026-07-01Diaz Allene M.Buy5.37K$79.19425.17K
2026-07-01BERTHELSEN SPENCER RBuy2.30K——
2026-07-01BERTHELSEN SPENCER RBuy5.37K$79.19425.17K
2026-06-26Baroldi JosephBuy1.77K$32.6057.67K
2026-06-26Baroldi JosephBuy3.87K$56.78219.51K
2026-06-26Baroldi JosephSell5.63K$80.16451.70K
2026-06-26Baroldi JosephSell3.87K$56.78219.51K
2026-06-26Baroldi JosephSell1.77K$32.6057.67K
2026-06-26O'NEIL PATRICK R.Sell3.07K$80.00245.52K
2026-06-26Schneider EugeneBuy26.00K$60.891.58M
2026-06-26Schneider EugeneSell26.00K$81.052.11M
2026-06-26Schneider EugeneSell26.00K$60.891.58M
2026-06-26Monia Brett PBuy50.00K$56.782.84M
2026-06-26Monia Brett PSell50.00K$80.594.03M
2026-06-26Monia Brett PSell50.00K$56.782.84M
2026-06-25Monia Brett PBuy21.07K$32.60686.95K
2026-06-25Monia Brett PSell21.07K$78.491.65M
2026-06-25Monia Brett PSell21.07K$32.60686.95K
2026-06-25Swayze EricSell10.60K$79.18839.49K
2026-06-24Monia Brett PBuy14.56K$32.60474.82K
2026-06-24Monia Brett PSell14.56K$78.411.14M
2026-06-24Monia Brett PSell14.56K$32.60474.82K
2026-06-15BERTHELSEN SPENCER RBuy8.00K$24.42195.36K
2026-06-15BERTHELSEN SPENCER RSell8.00K$73.49587.92K
2026-06-15BERTHELSEN SPENCER RSell8.00K$24.42195.36K
2026-06-12Kordasiewicz Holly B.Buy19.89K$56.781.13M
2026-06-12Kordasiewicz Holly B.Buy12.00K$32.60391.20K
2026-06-12Kordasiewicz Holly B.Buy21.00K$60.891.28M
2026-06-12Kordasiewicz Holly B.Sell41.00K$73.093.00M
2026-06-12Kordasiewicz Holly B.Buy7.95K$60.89484.14K
2026-06-12Kordasiewicz Holly B.Sell19.84K$74.051.47M
2026-06-12Kordasiewicz Holly B.Sell7.95K$60.89484.14K
2026-06-12Kordasiewicz Holly B.Sell12.00K$32.60391.20K
2026-06-12Kordasiewicz Holly B.Sell19.89K$56.781.13M
2026-06-12Kordasiewicz Holly B.Sell21.00K$60.891.28M
2026-06-04Reikes Peter NBuy10.75K$75.13807.87K
2026-06-04HANTSON LUDWIGBuy10.75K$75.13807.87K
2026-06-04Reikes Peter NOther0——
2026-06-04HANTSON LUDWIGOther0——
2026-06-01BERTHELSEN SPENCER RBuy8.00K$24.42195.36K
2026-06-01BERTHELSEN SPENCER RSell8.00K$75.67605.36K
2026-06-01BERTHELSEN SPENCER RSell8.00K$24.42195.36K
2026-05-14Monia Brett PBuy3.22K$32.60104.97K
2026-05-14Monia Brett PSell3.22K$78.68253.35K
2026-05-14Monia Brett PSell3.22K$32.60104.97K
2026-05-13Monia Brett PBuy1.32K$32.6042.90K
2026-05-13Monia Brett PSell1.32K$78.01102.67K
2026-05-13Monia Brett PSell1.32K$32.6042.90K
2026-05-04LOSCALZO JOSEPHBuy16.00K$64.801.04M
2026-05-04LOSCALZO JOSEPHBuy12.00K$60.20722.40K
2026-05-04LOSCALZO JOSEPHBuy16.00K$42.88686.08K
2026-05-04LOSCALZO JOSEPHBuy10.32K$41.08423.99K
2026-05-04LOSCALZO JOSEPHBuy12.00K$40.05480.60K
2026-05-04LOSCALZO JOSEPHSell59.51K$74.904.46M
2026-05-04LOSCALZO JOSEPHBuy10.97K$38.06417.44K
2026-05-04LOSCALZO JOSEPHSell17.78K$75.581.34M
2026-05-04LOSCALZO JOSEPHSell10.97K$38.06417.44K
2026-05-04LOSCALZO JOSEPHSell12.00K$40.05480.60K
2026-05-04LOSCALZO JOSEPHSell10.32K$41.08423.99K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 556, holders +29 vs prior quarter. Ownership 109.65%.

HolderSharesChangeChange %Value
FMR LLC24.63M75.32K+0.31%1.95B
CAPITAL WORLD INVESTORS21.67M482.86K+2.28%1.72B
BLACKROCK, INC.10.70M262.18K+2.51%848.77M
VANGUARD PORTFOLIO MANAGEMENT LLC7.86M50.63K+0.65%623.18M
WELLINGTON MANAGEMENT GROUP LLP7.65M1.26M+19.71%606.68M
VANGUARD CAPITAL MANAGEMENT LLC7.21M93.17K+1.31%571.80M
TWO SIGMA INVESTMENTS, LP6.25M394.71K+6.74%495.75M
ROYAL BANK OF CANADA6.18M2.38M+62.62%490.21M
STATE STREET CORP4.33M339.28K+8.49%343.71M
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.3.96M-2.20M-35.71%313.94M
GEODE CAPITAL MANAGEMENT, LLC3.58M-400.31K-10.05%294.75M
PRICE T ROWE ASSOCIATES INC /MD/3.18M159.25K+5.26%252.50M
JPMORGAN CHASE & CO2.67M308.15K+13.04%216.20M
ARTISAN PARTNERS LIMITED PARTNERSHIP2.64M581.72K+28.26%209.33M
TWEEDY, BROWNE CO LLC2.28M4.69K+0.21%180.81M
DEEP TRACK CAPITAL, LP2.20M250.00K+12.82%174.44M
GOLDMAN SACHS GROUP INC2.11M410.10K+24.13%167.30M
BAKER BROS. ADVISORS LP2.05M00.00%162.36M
DEERFIELD MANAGEMENT COMPANY, L.P.1.98M00.00%156.97M
AMERICAN CENTURY COMPANIES INC1.95M283.27K+17.03%154.38M
FRANKLIN TEMPLETON INC1.62M48.35K+3.07%128.72M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.1.61M1.61MNew127.26M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.61M21.79K+1.38%127.26M
BARCLAYS PLC1.60M1.31M+453.05%127.11M
PICTET ASSET MANAGEMENT HOLDING SA1.60M162.00K+11.29%126.98M

Earnings and financials

Ionis Pharmaceuticals, Inc. (IONS) trades at $43.96, with a market cap of $7.31B and a trailing P/E of -12.55. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
3727760005141790005996740001122599000729264000810456000587367000787647000705138000944000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Ionis Pharmaceuticals (IONS) Financials: Revenue & Earnings

IONS$43.960.00 0.00%

$7.31B

Market Cap

-12.55

P/E

109.71

Forward P/E

49

Score

Price History